Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - Deutsche Boerse Ag - FR0000120073 - Common Stock - Currency: EUR

175.12  -1.42 (-0.8%)

Fundamental Rating

5

Taking everything into account, AIL scores 5 out of 10 in our fundamental rating. AIL was compared to 68 industry peers in the Chemicals industry. While AIL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, AIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
AIL had a positive operating cash flow in the past year.
Each year in the past 5 years AIL has been profitable.
In the past 5 years AIL always reported a positive cash flow from operatings.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

The Return On Assets of AIL (6.37%) is better than 77.94% of its industry peers.
The Return On Equity of AIL (12.31%) is better than 76.47% of its industry peers.
AIL's Return On Invested Capital of 9.63% is amongst the best of the industry. AIL outperforms 86.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AIL is above the industry average of 6.10%.
The 3 year average ROIC (9.47%) for AIL is below the current ROIC(9.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROIC 9.63%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

AIL has a better Profit Margin (12.22%) than 88.24% of its industry peers.
AIL's Profit Margin has improved in the last couple of years.
AIL has a better Operating Margin (19.93%) than 92.65% of its industry peers.
AIL's Operating Margin has improved in the last couple of years.
The Gross Margin of AIL (63.01%) is better than 92.65% of its industry peers.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

AIL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AIL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AIL has been increased compared to 5 years ago.
The debt/assets ratio for AIL has been reduced compared to a year ago.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.88. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.88, AIL is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
AIL has a debt to FCF ratio of 4.43. This is a neutral value as AIL would need 4.43 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.43, AIL is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
AIL has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AIL (0.37) is better than 60.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Altman-Z 3.88
ROIC/WACC1.33
WACC7.23%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

AIL has a Current Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
AIL has a worse Current ratio (0.88) than 88.24% of its industry peers.
A Quick Ratio of 0.65 indicates that AIL may have some problems paying its short term obligations.
AIL has a worse Quick ratio (0.65) than 86.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.65
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.88% over the past year.
The Earnings Per Share has been growing by 11.55% on average over the past years. This is quite good.
AIL shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
AIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.30% yearly.
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%

3.2 Future

AIL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.15% yearly.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y10.15%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y4.06%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.23, which means the current valuation is very expensive for AIL.
AIL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, AIL is valued at the same level.
Based on the Price/Forward Earnings ratio of 24.78, the valuation of AIL can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as AIL.
When comparing the Price/Forward Earnings ratio of AIL to the average of the S&P500 Index (21.76), we can say AIL is valued inline with the index average.
Industry RankSector Rank
PE 27.23
Fwd PE 24.78
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIL.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AIL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.21
EV/EBITDA 14.21
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of AIL may justify a higher PE ratio.
PEG (NY)2.75
PEG (5Y)2.36
EPS Next 2Y10.48%
EPS Next 3Y10.45%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.
AIL's Dividend Yield is comparable with the industry average which is at 3.08.
AIL's Dividend Yield is slightly below the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.88%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AIL pays out 51.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.97%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (7/11/2025, 7:00:00 PM)

175.12

-1.42 (-0.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-22 2025-04-22
Earnings (Next)07-29 2025-07-29
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap101.30B
Analysts78.75
Price Target198.82 (13.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.88%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP51.97%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.27%
PT rev (3m)0.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 27.23
Fwd PE 24.78
P/S 3.74
P/FCF 36.21
P/OCF 16.02
P/B 3.77
P/tB 9.94
EV/EBITDA 14.21
EPS(TTM)6.43
EY3.67%
EPS(NY)7.07
Fwd EY4.04%
FCF(TTM)4.84
FCFY2.76%
OCF(TTM)10.93
OCFY6.24%
SpS46.78
BVpS46.44
TBVpS17.62
PEG (NY)2.75
PEG (5Y)2.36
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROCE 12.72%
ROIC 9.63%
ROICexc 10.08%
ROICexgc 17.03%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.34%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Debt/EBITDA 1.25
Cap/Depr 140.72%
Cap/Sales 13.03%
Interest Coverage 20.46
Cash Conversion 80.06%
Profit Quality 84.6%
Current Ratio 0.88
Quick Ratio 0.65
Altman-Z 3.88
F-Score8
WACC7.23%
ROIC/WACC1.33
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y10.15%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y4.06%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year58.93%
EBIT Next 3Y22.7%
EBIT Next 5Y15.83%
FCF growth 1Y-2.53%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y0.95%
OCF growth 3Y4.31%
OCF growth 5Y6.05%